Targeted Radionuclide Boosts Survival in Pancreatic Tumors ...Middle East

A phase 2 trial of lutetium-octreotate in patients with unresectable progressive pancreatic neuroendocrine tumors shows nearly double the 1-year survival rate compared with sunitinib at standard dose. Medscape Medical News

Hence then, the article about targeted radionuclide boosts survival in pancreatic tumors was published today ( Monday 17/10/2022 - 04:12 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Targeted Radionuclide Boosts Survival in Pancreatic Tumors )

Also on site :

• We Asked 3 Oncologists About the Worst Thing You Can Do for Cancer Risk and They All Said the Same Thing
• Dietitians Are Begging People to Stop Pairing This Common Supplement With Magnesium
• Across the Middle East, Muslims Mark Eid Amid War and Crisis